Differences

This shows you the differences between two versions of the page.

--- home:food:aim_health:aging [02.01.2019] – [General research on aging] sallieq
+++ home:food:aim_health:aging [02.01.2019] – [Long term treatment] sallieq
@@ Line 1: / Line 1: @@
-====== Aging and Olmesartan ======
+====== Health Maintenance and Olmesartan ======
 Summary of research on aging and Olmesartan
@@ Line 110: / Line 110: @@
 === Long term treatment ===
-Data suggest 40 & 80 mg olmesartan are able to significantly remodel & destiffen the arterial wall material during long-term treatment, partly independently of blood pressure, compared with 20 mg.
+ Patients receiving the highest dose of olmesartan (40 and 80 mg) had an inward carotid remodeling and were shifted toward a lower elastic modulus at a given circumferential wall stress, indicating an improvement in the intrinsic elastic properties of the carotid artery wall material. These data suggest that 40 and 80 mg olmesartan were able to significantly remodel and destiffen the arterial wall material during long-term treatment, partly independently of blood pressure, compared with 20 mg.
 //hyper.ahajournals.org/content/early/2014/07/07/HYPERTENSIONAHA.114.03282.reprint  (({{pubmed>long:25001274}}))
 {{tag>olmesartan Food_and_drink summary}}

home/food/aim_health/aging.txt · Last modified: 09.14.2022 by 127.0.0.1